Archives 13 juillet 1988 – Reportage chez la famille HERVOUET, exemple des dangers du DISTILBENE. – DANE HERVOUET, la mère, explique que ce médicament lui avait été ordonné au cours de ses grossesses et que ses enfants sont atteints de malformations génitales. Astrid, 20 ans ; Béatrice, 15 ans ; Yves, 17 ans qui a déjà subi 7 opérations. – Bureau de l’Association DES France, de défense des victimes du DISTILBENE. – Interview du Professeur Michel Tournaire, gynéologue à l’Hôpital Saint Vincent de Paul, sur l’importance d’informer les médecins. Brochure à l’intention des praticiens.
The anxiety one must feel when diagnosed with a condition that was thrust upon them
“I leave in a constant state of fear” explains a 48 year-old DES daughter who recently took her DES story to court as part of a 53-woman civil law suit. She was diagnosed with breast cancer two years ago and like all these women she was exposed to DES before birth. In this poignant video, she and her mother tell us about the guilt, anger and fear attached to this drug and how it is affecting their day to day lives.
Recent studies revealed that women exposed to Diethylstilbestrol before birth are now facing a myriad of serious health risks starting in their 40s and 50s.
The women in this study were followed as part of the National Cancer Institutes (NCI)’s DES Follow-up Study, which began in 1992.
The cancer risks for exposed daughters, as well as sons, are continually being studied as they age to determine if they differ from an unexposed population.
In addition, researchers are studying possible health effects on the grandchildren of mothers who took DES during pregnancy, because some of the genetic changes caused by DES exposure in the womb may be inherited.
Mark Sherry, Ph.D. Associate Professor of Sociology, has developed a series of YouTube videos to support his teaching (particularly for online classes) and discuss books that his students are studying.
Below is one of these videos in which he discusses “DES Daughters – Embodied Knowledge and the Transformation of Women’s Health Politics” a book by Susan E. Bell
The social action component of research and how DES activists forced medicine to change, how DES victims got together to force a federal task force to look into the DES issues and how a national registry was developed to record DES health issues
Late 1980s video published on Jul 12, 2012 by ShellerPC
Archival footage from late 1980s with Attorney Stephen Sheller, P.C. on AM Philadelphia which brings the DES matter to people’s attention and acknowledges the devastating side effects of this drug on women and men and over three generations.
One of the first worldwide drug scandal is DES (Diethylstilbestrol) affecting millions of people in countries where the anti miscarriage drug was widely prescribed to pregnant women decades ago. You may have been exposed to DES without knowing it! The time bomb effects and associated health issues on three generations are still being ignored.
Endocrine Disruptors and Lessons from DES Diethylstilbestrol
Pour plus d’information sur la journée tenue à l’Assemblée Nationale le 10 Avril 2012 vous pouvez lire cet article: Les Perturbateurs Endocriniens publié le 26 Avril dernier.
Intervention du Dr Annie J. Sasco, Médecin épidémiologiste du cancer, sur le thème “Effets transgénérationnels des perturbateurs endocriniens: les leçons du DES” lors de la table-ronde organisée par WECF le 10 avril sur le thème “Perturbateurs endocriniens, effets et mécanismes d’action de la conception à la maturité”.
On Tuesday 10th April 2012, the French National Assembly hosted a debate around the harmful effects of endocrine disruptors to convince governments to take action. French and foreign Endocrine Disruptors (ED) specialists attended the event, gave presentations and discussed the many issues associated with ED. Among them was Dr. Annie J. Sasco , Cancer epidemiologist, INSERM Research Director, University of Bordeaux, France, who worked on the transgenerational effects of endocrine disruptors, more specifically those of DES: “I am very pessimistic. For 30 years, cancer has doubled in the world. The DES tragedy is not enough. Even though DES was registered in 1939 in Britain on the poisons’ list, and it had been proven it was ineffective for the prevention of miscarriage since 1953, nothing prevented this drug from being widely produced and prescribed. It has been recognized as a carcinogenic drug since 1974, and it is now proven to have effects on the third generation in terms of risk of cancer, including ovarian and genital malformation rate 18 times higher than normal. We’ve just banned Bisphenol A in baby bottles yet the risks were known since the 30s. Another example is hormone replacement therapy: its extended use to 10 years of treatment is associated with an increased risk of cancer. ”
You can find more information about this debate by reading this article published on April, 26th (approximate translation by Google).
Diethylstilbestrol in utero exposure and cancers risk, 2011
From Maryland – Exposure to Diethylstilbestrol in the womb raises a woman’s risk of many cancers, according to a report published in the New England Journal of Medicine. Researchers studied over 6500 women, 4600 of whom were exposed to DES in the womb. Results showed that this exposure significantly increased risk of many cancers and fertility problems, including a 40x increased risk of clear-cell adenocarcinoma, 8x increased risk of neonatal death, 2.4x increased risk of infertility and a 1.8x increased risk of breast cancer.